XML 33 R20.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Stockholders' Equity (Tables) | 6 Months Ended
--- | ---
Sep. 30, 2017
Stockholders' Equity Note [Abstract] |
Stock Option Transactions Under Stock Option Plans | Stock option activity for the six months ended September 30, 2017 is summarized below:
|  |  |  | Weighted |  | Weighted |  | Weighted |
|  |  |  | Average |  | Average |  | Average |
|  |  |  | Per Share |  | Remaining |  | Per Share |
|  |  |  | Exercise |  | Life |  | Intrinsic |
|  | Shares |  | Price |  | (Years) |  | Value |
Balance, March 31, 2017 |  |  | 1,165,350 |  | $ | 4.24 |  |  | 6.64 |  | $ | 4.86 |
Granted |  |  | 80,000 |  |  | 9.71 |  |  | - |  |  | - |
Exercised |  |  | - |  |  | - |  |  | - |  |  | - |
Cancelled/expired |  |  | (33,000) |  |  | 9.62 |  |  | - |  |  | - |
Balance, September 30, 2017 |  |  | 1,212,350 |  | $ | 4.42 |  |  | 6.36 |  | $ | 5.35 |
Vested, September 30, 2017 |  |  | 1,040,840 |  | $ | 4.04 |  |  | 5.92 |  | $ | 5.74 |
Summary of Stock Based Compensation Expense Related To Restricted Stock and Option Awards | Stock-based compensation expense related to common stock option awards is recognized over their respective vesting periods and was included in the accompanying condensed consolidated statement of operations as follows:
|  | Three Months Ended |  | Six Months Ended |
|  | September 30, |  | September 30, |
|  | 2017 |  | 2016 |  | 2017 |  | 2016 |
Stock-based compensation expense: |  |  |  |  |  |  |  |  |  |  |  |  |
Cost of services |  | $ | - |  | $ | 1,227 |  | $ | - |  | $ | 2,454 |
General and administrative |  |  | 195,244 |  |  | 244,814 |  |  | 418,810 |  |  | 491,304 |
|  | $ | 195,244 |  | $ | 246,041 |  | $ | 418,810 |  | $ | 493,758 |
Warrants Outstanding | Warrants consisted of the following for the six months ended September 30, 2017:
|  | Weighted |  |  |
|  | Average |  |  |
|  | Per Share |  |  |
|  | Intrinsic |  | Number of |
|  | Value |  | Warrants |
Outstanding at March 31, 2017 |  | $ | 4.68 |  |  | 1,970,166 |
Granted |  |  | - |  |  | - |
Exercised |  |  | 5.09 |  |  | (19,000) |
Cancelled |  |  | - |  |  | - |
Outstanding at September 30, 2017 |  | $ | 1.34 |  |  | 1,951,166 |
|  |  |  |  |  | Weighted |  |  |  |  |  | Weighted |
|  |  |  |  |  | Average |  |  |  |  |  | Average |
Exercise Price Per |  |  | Warrants |  |  | Remaining |  |  | Warrants |  |  | Exercise Price Per |
Share |  |  | Outstanding |  |  | Contractual Life |  |  | Exercisable |  |  | Share |
| $4.00-$5.00 |  |  |  | 169,500 | [1] |  |  | 0.39 |  |  |  | 169,500 |  |  |  | 4.46 |
| $9.00-$10.00 |  |  |  | 1,781,666 | [2] |  |  | 3.04 |  |  |  | 1,781,666 |  |  |  | 9.37 |
| $4.00-$10.00 |  |  |  | 1,951,166 |  |  |  | 2.81 |  |  |  | 1,951,166 |  |  | $ | 8.94 |
[1] Such warrants outstanding as of September 30, 2017 comprise warrants issued in October 2009 in connection with the Company’s 10% Senior Subordinated Callable Convertible Notes and warrants issued in January 2013 in connection with the Company’s 9% Senior Subordinated Callable Convertible Promissory Notes. The 2009 warrants have expired as of the date of this Quarterly Report on Form 10-Q. The 2013 warrants may be exercised at an exercise price of $4.50 per share at any time until the end of January 2018. In addition, in November, 2016, in connection with the acquisition of BAHA, the Company issued to Scott Enderby, D.O., a warrant to purchase 24,000 shares of Common Stock at an exercise price of $4.50 per share. [2] In July 2014, in connection with the acquisition of SCHC, the Company issued to Stanley Lau, M.D., and Yih Jen Kok, M.D., warrants to purchase up to 100,000 shares of Common Stock (on a post stock-split basis) at an exercise price of $10.00 per share exercisable until July 21, 2018. In February 2015, in consideration of services rendered to the Company, the Company issued to RedChip Companies, Inc. a warrant to purchase up to 10,000 shares of Common Stock (on a post stock-split basis) at an exercise price of $9.00 per share exercisable until February 20, 2018. In connection with NMM’s investments in the Company, in October, 2015 and March 2016, respectively, the Company issued to NMM a stock purchase warrant (the “Series A Warrant”) to purchase up to 1,111,111 shares of Common Stock at an exercise price of $9.00 per share, and a stock purchase warrant (the “Series B Warrant”) to purchase up to 555,555 shares of Common Stock at an exercise price of $10.00 per share. In November, 2016, in connection with a promissory note issued to Liviu Chindris, M.D., which the Company has repaid in full, the Company issued to Dr. Chindris a warrant to purchase up to 5,000 shares of Common Stock at an exercise price of $9.00 per share.
Amount of Shares of Common Stock Reserved | The number of shares of Common Stock reserved for these purposes is as follows as of September 30, 2017:
For warrants outstanding |  |  | 1,951,166 |
For stock options outstanding |  |  | 1,212,350 |
For debt outstanding and accrued interest |  |  | 514,093 |
For preferred stock issued and outstanding |  |  | 1,666,666 |
Total |  |  | 5,344,275 |

X
- Definition Schedule Of Common Stock Reserved For Future Issuance [Table Text Block] + References No definition available. + Details
Name: | ameh_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock
Namespace Prefix: | ameh_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the amount of total share-based compensation cost, including the amounts attributable to each share-based compensation plan and any related tax benefits. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(i)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=96867065&loc=d3e5047-113901 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -Section S99 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=68057994&loc=d3e25284-112666 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration